Trailing-twelve-month (TTM) revenue is $2.33 Billion with a year-over-year growth of +13.63%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $530,888,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q3 FY2026Period ended 2025-12-31 | $615,574,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-09 |
| Q4 FY2026Period ended 2026-03-31 | $466,698,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-01 |
| Q1 FY2027Period ended 2026-06-30 | $720,882,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $2,334,042,000 |
Current P/S: $10,755,778,680 market capitalization ÷ $2,334,042,000 TTM revenue = 4.61x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:44:54.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $720.88M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:46:50.389Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|
| Banking Segment | $615M | $506M | $689M |
| Brokerage Segment | $617M | $717M | $832M |
| Insurance Segment | $341M | $683M | $498M |
| Other Segment | $62M | $144M | $173M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|
| ARMENIA | N/A | N/A | $182M | $182M |
| Asia | $118M | N/A | N/A | N/A |
| Central Asia and Eastern Europe | N/A | $566M |
$2.33B
$2.33 Billion
+13.63%
vs. $2.05B a year ago (TTM)
+42.42%
5 Year compound annual growth rate
1 Year
+13.63%
3 Year
+39.59%
5 Year
+42.42%
10 Year
+116.33%
15 Year
N/A
20 Year
+33.12%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.19B | +$157.84M | +7.76% |
| 2025 | $2.03B | +$376.80M | +22.74% |
| 2024 | $1.66B | +$860.96M | +108.20% |
| 2023 | $795.69M | +$105.90M | +15.35% |
| 2022 | $689.79M | +$342.91M | +98.85% |
| 2021 |
TTM Growth
+13.63%
3-Year CAGR
+39.59%
5-Year CAGR
+42.42%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| CYPRUS | N/A | N/A | $69M | $154M |
|---|
| Europe | $438M | N/A | N/A | N/A |
|---|
| Europe, excluding Eastern Europe | N/A | $217M | N/A | N/A |
|---|
| KAZAKHSTAN | N/A | N/A | $1.8B | $1.8B |
|---|
| Other Countries | N/A | N/A | $5M | $14M |
|---|
| UNITED STATES | $9M | $13M | $44M | $3M |
|---|
| $346.88M |
| +$263.49M |
| +315.96% |
| 2020 | $83.39M | +$9.11M | +12.26% |
| 2019 | $74.28M | +$16.53M | +28.62% |
| 2018 | $57.76M | +$38.40M | +198.38% |
| 2017 | $19.36M | ($37.92M) | (66.20%) |
